{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:31:37Z","timestamp":1780464697511,"version":"3.54.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s12185-022-03345-5","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T08:02:46Z","timestamp":1650355366000},"page":"630-634","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Successful HLA-haploidentical stem cell transplantation with post-transplant cyclophosphamide in an older patient with chronic active Epstein\u2013Barr virus infection"],"prefix":"10.1007","volume":"116","author":[{"given":"Masaya","family":"Maegaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Hosoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzuru","family":"Hosoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-Ichi","family":"Imadome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Motokura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4632-8429","authenticated-orcid":false,"given":"Tetsuya","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,18]]},"reference":[{"key":"3345_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fped.2019.00014","volume":"7","author":"A Arai","year":"2019","unstructured":"Arai A. Advances in the study of chronic active Epstein-Barr virus infection: clinical features under the 2016 WHO classification and mechanisms of development. Front Pediatr. 2019;7:14.","journal-title":"Front Pediatr"},{"issue":"4","key":"3345_CR2","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s12185-017-2192-6","volume":"105","author":"A Sawada","year":"2017","unstructured":"Sawada A, Inoue M, Kawa K. How we treat chronic active Epstein-Barr virus infection. Int J Hematol. 2017;105(4):406\u201318.","journal-title":"Int J Hematol"},{"key":"3345_CR3","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3389\/fped.2018.00334","volume":"6","author":"A Sawada","year":"2018","unstructured":"Sawada A, Inoue M. Hematopoietic stem cell transplantation for the treatment of Epstein-Barr virus-associated T- or NK-cell lymphoproliferative diseases and associated disorders. Front Pediatr. 2018;6:334.","journal-title":"Front Pediatr"},{"issue":"38","key":"3345_CR4","doi-asserted-by":"publisher","first-page":"63574","DOI":"10.18632\/oncotarget.18862","volume":"8","author":"Gu Zhenyang","year":"2017","unstructured":"Zhenyang Gu, Wang Li, Yuan L, Huang W, Li M, Guan L. Similar outcomes after haploidentical transplantation with post-transplant cyclophosphamide versus HLA-matched transplantation: a meta-analysis of case-control studies. Oncotarget. 2017;8(38):63574\u201386.","journal-title":"Oncotarget"},{"issue":"13","key":"3345_CR5","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1182\/bloodadvances.2020001451","volume":"4","author":"I Yonese","year":"2020","unstructured":"Yonese I, Sakashita C, Imadome KI, Kobayashi T, Yamamoto M, Sawada A, et al. Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification. Blood Adv. 2020;4(13):2918\u201326.","journal-title":"Blood Adv"},{"issue":"5","key":"3345_CR6","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s12185-011-0831-x","volume":"93","author":"A Arai","year":"2011","unstructured":"Arai A, Imadome KI, Watanabe Y, Yoshimori M, Koyama T, Kawaguchi T, et al. Clinical features of adult-onset chronic active Epstein-Barr virus infection: a retrospective analysis. Int J Hematol. 2011;93(5):602\u20139.","journal-title":"Int J Hematol"},{"issue":"6","key":"3345_CR7","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/bmt.2016.3","volume":"51","author":"A Arai","year":"2016","unstructured":"Arai A, Sakashita C, Hirose C, Imadome KI, Yamamoto M, Jinta M, et al. Hematopoietic stem cell transplantation for adults with EBV-positive T- or NK-cell lymphoproliferative disorders: efficacy and predictive markers. Bone Marrow Transpl. 2016;51(6):879\u201382.","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"3345_CR8","first-page":"286","volume":"60","author":"S Suma","year":"2019","unstructured":"Suma S, Kurita N, Baba N, Ishitsuka K, Sukegawa S, Makishima K, et al. Fatal exacerbations of chronic active Epstein-Barr virus infection subsequent to cytotoxic chemotherapy. Rinsho Ketsueki. 2019;60(4):286\u201390.","journal-title":"Rinsho Ketsueki"},{"issue":"2","key":"3345_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.bbmt.2013.10.026","volume":"20","author":"A Sawada","year":"2014","unstructured":"Sawada A, Inoue M, Koyama-Sato M, Kondo O, Yamada K, Shimizu M, et al. Umbilical cord blood as an alternative source of reduced-intensity hematopoietic stem cell transplantation for chronic Epstein-Barr virus-associated T or natural killer cell lymphoproliferative diseases. Biol Blood Marrow Transpl. 2014;20(2):214\u201321.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"12","key":"3345_CR10","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1001\/jamaoncol.2019.3541","volume":"5","author":"N Gagelmann","year":"2019","unstructured":"Gagelmann N, Bacigalupo A, Rambaldi A, Hoelzer D, Halter J, Sanz J, et al. Haploidentical stem cell transplantation with posttransplant cyclophosphamide therapy vs other donor transplantations in adults with hematologic cancers: a systematic review and meta-analysis. JAMA Oncol. 2019;5(12):1739\u201348.","journal-title":"JAMA Oncol"},{"issue":"10","key":"3345_CR11","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1093\/jjco\/hyz099","volume":"49","author":"K Poonsombudlert","year":"2019","unstructured":"Poonsombudlert K, Kewcharoen J, Prueksapraopong C, Limpruttidham N. Post-transplant cyclophosphamide based haplo-identical transplant versus umbilical cord blood transplant; a meta-analysis. Jpn J Clin Oncol. 2019;49(10):924\u201331.","journal-title":"Jpn J Clin Oncol"},{"issue":"14","key":"3345_CR12","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1200\/JCO.19.02408","volume":"38","author":"G Fatobene","year":"2020","unstructured":"Fatobene G, Rocha V, Martin AS, Hamadani M, Robinson S, Bashey A, et al. Nonmyeloablative alternative donor transplantation for hodgkin and non-hodgkin lymphoma: from the LWP-EBMT, Eurocord, and CIBMTR. J Clin Oncol. 2020;38(14):1518\u201326.","journal-title":"J Clin Oncol"},{"issue":"2","key":"3345_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3324\/haematol.2016.151779","volume":"102","author":"A Ruggeri","year":"2017","unstructured":"Ruggeri A, Sun Y, Labopin M, Bacigalupo A, Lorentino F, Arcese W, et al. Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant. Haematologica. 2017;102(2):401\u201310.","journal-title":"Haematologica"},{"issue":"6","key":"3345_CR14","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.3324\/haematol.2020.247296","volume":"106","author":"A Nagler","year":"2021","unstructured":"Nagler A, Kanate AS, Labopin M, Ciceri F, Angelucci E, Koc Y, et al. Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia. Haematologica. 2021;106(6):1591\u20138.","journal-title":"Haematologica"},{"key":"3345_CR15","doi-asserted-by":"crossref","unstructured":"Styczynski J, van der Velden W, Fox CP, Engelhard D, de la Camara R, Cordonnier C, et al. Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines. Haematologica. Jul 2016;101(7):803\u201311.","DOI":"10.3324\/haematol.2016.144428"},{"issue":"7","key":"3345_CR16","first-page":"2208","volume":"94","author":"RE Curtis","year":"1999","unstructured":"Curtis RE, Travis LB, Rowlings PA, Soci\u00e9 G, Kingma DW, Banks PM, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood. 1999;94(7):2208\u201316.","journal-title":"Blood"},{"issue":"10","key":"3345_CR17","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.bbmt.2013.07.013","volume":"19","author":"JA Kanakry","year":"2013","unstructured":"Kanakry JA, Kasamon YL, Bola\u00f1os-Meade J, Borrello IM, Brodsky RA, Fuchs EJ, et al. Absence of post-transplantation lymphoproliferative disorder after allogeneic blood or marrow transplantation using post-transplantation cyclophosphamide as graft-versus-host disease prophylaxis. Biol Blood Marrow Transplant. 2013;19(10):1514\u20137.","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03345-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-022-03345-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03345-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T18:46:15Z","timestamp":1664304375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-022-03345-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,18]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["3345"],"URL":"https:\/\/doi.org\/10.1007\/s12185-022-03345-5","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,18]]},"assertion":[{"value":"19 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}